Zomedica Corp. announced the commercial launch of three new assays: Canine Pancreatic Lipase (cPL), Cobalamin (B12) and Folate, for the TRUFORMA®? In-Clinic Biosensor Testing Platform.

offer three of the most common assays for these cases: Canine Pancreatic Lipase (cPL), Cobalamin (B12), and Folate, to help diagnose pancreatitis and irritable bowel disease (IBD), respectively. The company believed through these assays can help veterinarians produce better outcomes for pets and pet parents by providing faster diagnostic solutions, while also streamlining their workflow and increasing practice profitability. For cPL, veterinarians have historically needed to choose between a rapid in-clinic diagnostic and a high-quality reference lab test which typically meant waiting for results until at least the next day.

The TRUFORMA cPL test delivers reference lab quality results at the point of care.